<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation-group" /><meta name="keywords" content="Venlafaxine; Alventa XL (venlafaxine); Bonilux XL (venlafaxine); Depefex XL (venlafaxine); Foraven XL (venlafaxine); Politid XL (venlafaxine); Ranfaxine XL (venlafaxine); Tifaxin XL (venlafaxine); Venaxx XL (venlafaxine); Vensir XL (venlafaxine); Winfex XL (venlafaxine); Venlalic XL (venlafaxine); Efexor XL; Venlafaxine" /><meta name="IX" content="Venlafaxine; Alventa XL (venlafaxine); Bonilux XL (venlafaxine); Depefex XL (venlafaxine); Foraven XL (venlafaxine); Politid XL (venlafaxine); Ranfaxine XL (venlafaxine); Tifaxin XL (venlafaxine); Venaxx XL (venlafaxine); Vensir XL (venlafaxine); Winfex XL (venlafaxine); Venlalic XL (venlafaxine); Efexor XL; Venlafaxine" /><title>Modified release: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="106066.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="106066.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=106066.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3294.htm">4.3 Antidepressant drugs</a> &gt; <a href="3358.htm">4.3.4 Other antidepressant drugs</a> &gt; <a href="27102.htm">VENLAFAXINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="17513.htm" title="Previous: TRYPTOPHAN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="3373.htm" title="Next: 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a394020.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Psychotherapeutic Agents 28:16 &gt; Antidepressants 28:16.04 &gt; Selective Serotonin- and Norepinephrine-reuptake Inhibitors 28:16.04.16</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/21820-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Venlafaxine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Venlafaxine</p></div></li></ul><ul><li><h3>British National Formulary (5)</h3></li><li><a href="3358.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.3.4 Other antidepressant drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.3 Antidepressant drugs</p></div></li><li><a href="27102.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VENLAFAXINE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.3 Antidepressant drugs &gt; 4.3.4 Other antidepressant drugs</p></div></li><li><a href="202780.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.3 Antidepressant drugs &gt; 4.3.4 Other antidepressant drugs &gt; VENLAFAXINE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22venlafaxine%22%22venlafaxine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c34-mn0001-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0021s0045.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/10487-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antidepressants &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09946.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; V &gt; VE</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D102.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Venlafaxine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c380.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; V</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_27102">VENLAFAXINE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i240.htm" title="Go to appendix 1">Venlafaxine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">major depression, generalised anxiety disorder</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">heart disease (monitor
blood pressure); diabetes; history of epilepsy; history or family history
of mania; susceptibility to angle-closure glaucoma; concomitant use of drugs that increase risk of bleeding, history of bleeding disorders; <b>interactions:</b> Appendix 1 (<span>venlafaxine</span>)</p><div class="cAV"><h3>Driving</h3> <p class="cAX">May affect performance of
skilled tasks (e.g. driving)</p></div><div class="cAV"><h3>Withdrawal</h3> <p class="cAX">Gastro-intestinal disturbances, headache,
anxiety, dizziness, paraesthesia, tremor, sleep disturbances, and
sweating are most common features of withdrawal if treatment stopped
abruptly or if dose reduced markedly; dose should be reduced over
several weeks</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">conditions associated with high
risk of cardiac arrhythmia, uncontrolled hypertension</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">consider reducing dose by 50% in mild or moderate impairment;
use with caution and reduce dose by at least 50% in severe impairment</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">use with caution; use half normal dose (immediate-release
tablets may be given once daily) if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">avoid unless potential benefit outweighs risk—toxicity
in <i>animal</i> studies; risk of withdrawal effects in
neonate</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">present in milk—avoid</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">constipation, nausea, anorexia, weight changes,
vomiting; hypertension, palpitation, vasodilatation, changes in serum
cholesterol; chills, yawning; dizziness, dry mouth, insomnia, nervousness,
drowsiness, asthenia, headache, abnormal dreams, anxiety, confusion,
hypertonia, sensory disturbances, tremor; difficulty with micturition,
sexual dysfunction, menstrual disturbances; visual disturbances, mydriasis
(<i>very rarely</i> angle-closure glaucoma); sweating; <i>less commonly</i> bruxism, diarrhoea, taste disturbance, postural
hypotension, arrhythmias, agitation, apathy, incoordination, hallucinations,
myoclonus, angioedema, urinary retention, bleeding disorders (including
ecchymosis and gastro-intestinal haemorrhage), tinnitus, alopecia,
photosensitivity, and rash; <i>rarely</i> mania, hypomania,
seizures, extrapyramidal symptoms including akathisia, urinary incontinence; <i>also reported</i> hepatitis, pancreatitis, hypotension, QT-interval
prolongation, aggression, neuroleptic malignant syndrome, delirium,
vertigo, syndrome of inappropriate anti-diuretic hormone secretion
(see <a title="target-block: Antidepressants CSM advice hyponatraemia" href="3294.htm#_120535">Hyponatraemia and Antidepressant
Therapy</a>),
hyperprolactinaemia, blood dyscrasias, rhabdomyolysis, pruritus, urticaria,
Stevens-Johnson syndrome; suicidal behaviour (see <a title="target-block: antidepressants and suicide" href="3294.htm#_3294.1">Suicidal Behaviour and Antidepressant
Therapy</a>)</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Depression, <span class="cAK">adult</span> over
18 years, initially 75 mg daily in 2 divided doses increased if necessary
at intervals of at least 2 weeks; max. 375 mg daily; <span class="cAK">child</span> under 18 years not recommended (see <a title="target-block: CSM advice depression in children" href="3351.htm#_3351.3">Depressive Illness in Children
and Adolescents</a>)</p><div class="cAT"><h3>Note</h3> <p class="cAX">Faster dose titration may be necessary in
some patients</p></div><p class="cR">Generalised anxiety disorder and social anxiety disorder, see
under preparations below</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="202780.htm#_202780" title="Venlafaxine">Venlafaxine</a></li><li class="jN" id="_106066" style="margin: 0 0 0 20px;"><h1 class="title">Modified release</h1><ul><li><a href="208497.htm#_208497" title="Venlafaxine m/r preparations">Venlafaxine m/r preparations</a></li><li><a href="65175.htm#_65175" title="Efexor® XL">Efexor® XL</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="17513.htm">Previous: TRYPTOPHAN</a> | <a class="top" href="106066.htm#">Top</a> | <a accesskey="]" href="3373.htm">Next: 4.4 CNS
stimulants and drugs used for attention deficit hyperactivity disorder</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>